|
Published by: PJB Publications USA Inc.
Published: Jun. 1, 2003
Table of Contents
1 Executive Summary
- 1.1 Scope of the Report
- 1.2 Methodology
2 Introduction and Overview
- 2.1 Definition and Types of Sleep Disorders
- 2.1.1 Problems With Staying and Falling Asleep
- 2.1.2 Problems Staying Awake
- 2.1.3 Problems With Adhering to a Regular Sleep Schedule
- 2.1.4 Sleep Disruptive Behaviors
- 2.2 Prevalence and Demographics
- 2.2.1 Women
- 2.2.2 The Elderly
- 2.2.3 Quality-of-Life and Socioeconomic Impact of Sleep Disorders
- 2.3 Non-Prescription and Natural Treatment Trends
- 2.3.1 Indications for Usage
- 2.3.2 United States
- 2.3.3 Europe
- 2.3.4 South America and Central America
- 2.3.5 Japan
- 2.4 Prescription Products and Alternative Treatments
3 U.S. Market
- 3.1 Market Overview
- 3.1.1 Self Care
- 3.1.2 Sleep Disorders in U.S
- 3.1.3 Treatment Usage
- 3.1.4 Research and Development
- 3.2 Regulatory Environment
- 3.2.1 OTC/Non-Prescription Sleep Aids
- 3.2.2 Dietary Supplements
- 3.2.3 Stimulant Products
- 3.2.4 Snoring Products
- 3.2.5 Homeopathic Products
- 3.3 Major Sleep Aid Segments
- 3.3.1 Antihistamine-Only Sleep Aids
- 3.3.2 Sleep Aids With Analgesics
- 3.3.3 Stimulant Products
- 3.3.4 Dietary Supplements
- 3.4 Ingredient Review
- 3.4.1 Antihistamines: Diphenhydramine, Doxylamine, Promethazine
- 3.4.2 Melatonin
- 3.4.3 5-HTP
- 3.4.4 Magnesiu
- 3.4.5 Caffeine
- 3.4.6 Ephedra
- 3.4.7 Herbals
- 3.5 Leading Brands
- 3.6 Market Size and Growth Analysis
- 3.6.1 Overall OTC Sleep Aids Market
- 3.6.2 Antihistamine-Only Sleep Aids
- 3.6.3 Antihistamine/Analgesic Sleep Aids (PM Products)
- 3.6.4 Dietary Supplement Sleep Aids
- 3.6.5 Stimulant Products
- 3.6.6 Natural Snoring Products
- 3.7 Competitor Analysis
- 3.7.1 Bayer
- 3.7.2 Blairex
- 3.7.3 Bristol-Myers Squibb
- 3.7.4 GlaxoSmithKline
- 3.7.5 Hylands
- 3.7.6 McNeil
- 3.7.7 Pfizer
4 Canadian Market
- 4.1 Regulatory Environment
- 4.2 Leading Brands
- 4.3 Market Size and Growth Analysis
5 Western European Market
- 5.1 Market Overview
- 5.2 Regulatory Environment
- 5.3 Ingredient Review
- 5.3.1 Antihistamines: Diphenhydramine, Doxylamine, Promethazine
- 5.3.2 Herbals
- 5.3.3 Lithium
- 5.4 Leading Brands
- 5.4.1 Pan-European Products?
- 5.4.2 Germany
- 5.4.3 France
- 5.4.4 United Kingdom
- 5.4.5 Italy
- 5.4.6 Spain
- 5.5 Market Size And Growth Analysis
- 5.5.1 Overall OTC Sleep Aids Market
- 5.5.2 Germany
- 5.5.3 France
- 5.5.4 United Kingdom
- 5.5.5 Italy
- 5.5.6 Spain
6 South and Central American Market
- 6.1 Leading Brands
- 6.1.1 Brazil
- 6.1.2 Argentina
- 6.1.3 Mexico
- 6.2 Market Size and Growth Analysis
- 6.2.1 Brazil
- 6.2.2 Argentina
- 6.2.3 Mexico
- 6.2.4 Other Countries: Negligible Markets?
7 Japanese Market
- 7.1 Leading Brands
- 7.2 Market Size and Growth Analysis
8 Company Briefs
- 8.1 Bayer AG
- 8.2 Bausch & Lom
- 8.3 Bristol-Myers Squibb
- 8.4 CNS Inc.
- 8.5 GlaxoSmithKl
- 8.6 Johnson & J
- 8.7 Merck KGaA
- 8.8 Pfizer, Inc.
- 8.9 Stada Arzneimittel AG
- 8.10 Solvay S.A
- 8.11 Wyeth
AbstractThe National Sleep Foundation (NSF)
annual surveys show a substantial rise
in the number of sleep disorders cases
and an increase in the usage of sleep aid
medications, both prescription and non
prescription.
Theta's report provides a general overview
of the market for over-the-counter (OTC)
medicines, as well as natural products, such
as dietary supplements and homeopathic
alternatives.
Product categories discussed in this report:
- OTC/non-prescriptionsleep aids
- PM products: antihistamine/analgesic combinations
- Natural products:
- dietary supplements
- herbal products
- specialty products
- homeopathic remedies
- Stimulant products
- Products to treat snoring
Four main disorder categories discussed:
- Problems with staying and falling asleep
- Problems with staying awake
- Problems with adhering to a regular sleep schedule
- Sleep disruptive behaviors
Please Note: Theta requires that, for PDF orders, clients sign a confidentiality agreement prior to fulfillment of PDF email delivery.
Get Full Details About This Report >>
|
